Skip to main content

previous disabled Page of 2
and
  1. Article

    Allergic rhinitis

    Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens and is one of the most common chronic conditions globally. AR often co-occurs with asthma and conjunctivitis a...

    Jean Bousquet, Josep M. Anto, Claus Bachert in Nature Reviews Disease Primers (2020)

  2. Article

    Open Access

    Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

    There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating la...

    Jean Bousquet, Jean-Paul Cristol in Clinical and Translational Allergy (2020)

  3. Article

    Open Access

    Anomalous asthma and chronic obstructive pulmonary disease Google Trends patterns during the COVID-19 pandemic

    An increase in online searches on health topics may either mirror epidemiological changes or reflect media coverage. In the context of COVID-19, this is particularly relevant, as COVID-19 symptoms may be mista...

    Bernardo Sousa-Pinto, Enrico Heffler, Aram Antó in Clinical and Translational Allergy (2020)

  4. Article

    Open Access

    Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    An amendment to this paper has been published and can be accessed via the original article.

    Jean Bousquet, Josep M. Anto, Guido Iaccarino in Clinical and Translational Allergy (2020)

  5. Article

    Open Access

    Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    Reported COVID-19 deaths in Germany are relatively low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward. Most curren...

    Jean Bousquet, Josep M. Anto, Guido Iaccarino in Clinical and Translational Allergy (2020)

  6. Article

    Open Access

    A Charter to Improve Patient Care in Severe Asthma

    Severe asthma is a subtype of asthma that is difficult to treat and control. By conservative estimates, severe asthma affects approximately 5–10% of patients with asthma worldwide. Severe asthma impairs patien...

    Andrew Menzies-Gow, G-Walter Canonica, Tonya A. Winders in Advances in Therapy (2018)

  7. Article

    Open Access

    Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

    Marek L. Kowalski, Ignacio Ansotegui, Werner Aberer in World Allergy Organization Journal (2017)

  8. Article

    Open Access

    Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

    Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on...

    F. Braido, N. Scichilone, F. Lavorini, O. S. Usmani in World Allergy Organization Journal (2016)

  9. Article

    Open Access

    Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

    Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on...

    F. Braido, N. Scichilone, F. Lavorini, O. S. Usmani in Asthma Research and Practice (2016)

  10. Article

    Open Access

    Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

    One of the major concerns in the practice of allergy is related to the safety of procedures for the diagnosis and treatment of allergic disease. Management (diagnosis and treatment) of hypersensitivity disorde...

    Marek L. Kowalski, Ignacio Ansotegui, Werner Aberer in World Allergy Organization Journal (2016)

  11. Article

    Open Access

    The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey

    The affliction of allergic rhinitis (AR) has been trivialised in the past. Recent initiatives by the European Academy of Allergy & Clinical Immunology and by the EU parliament seek to rectify that situation. T...

    David Price, Glenis Scadding, Dermot Ryan in Clinical and Translational Allergy (2015)

  12. Article

    Open Access

    360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients

    General practitioners (GPs), community pharmacists and allergic rhinitis (AR) patients in Italy were surveyed in order to gain insight from all three perspectives into the diagnosis, management and burden of A...

    G. Walter Canonica, Massimo Triggiani, GianEnrico Senna in Clinical and Molecular Allergy (2015)

  13. Article

    Open Access

    A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress

    The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doc...

    Peter W. Hellings, Antonella Muraro, Wytske Fokkens in Clinical and Translational Allergy (2015)

  14. Article

    Open Access

    ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

    Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the ...

    Karsten Weller, Marcus Maurer, Clive Grattan in Clinical and Translational Allergy (2015)

  15. Article

    Open Access

    A new AR therapy (MP29-02*): all of ARIA in one puff

    Ralph Mösges, Ludger Klimek, Carlos Baena-Cagnani in Clinical and Translational Allergy (2015)

  16. Article

    Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients

    Pierluigi Mauri, Annamaria Riccio, Rossana Rossi in World Allergy Organization Journal (2014)

  17. Article

    Open Access

    Poster 1001: ALLERGENIUS®: an expert system for the interpretation of allergen microarrays

    G Walter Canonica, Giovanni Passalacqua in World Allergy Organization Journal (2014)

  18. Article

    Open Access

    Immunotherapy – 2082. Long term prevention of asthma and rhinitis in children with atopic dermatitis four year after discontinuation of sublingual immunotherapy

    Giovanni Passalacqua, Valentina Garelli in World Allergy Organization Journal (2013)

  19. Article

    Open Access

    Review of Desloratadine Data Using the ARIA Guidelines

    Elisa Villa, Anthi Rogkakou, Valentina Garelli in World Allergy Organization Journal (2012)

  20. Article

    Open Access

    Persistent Allergic Rhinitis and the XPERT Study

    Allergic rhinitis (AR) is a chronic disease with an increasing trend in most of the Western Countries. It may significantly impair the individual quality of life (QoL) and also represents a social burden for i...

    Anthi Rogkakou, Elisa Villa, Valentina Garelli in World Allergy Organization Journal (2011)

previous disabled Page of 2